Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy
Autor: | Gertz, Morie A. *, Lacy, Martha Q., Dispenzieri, Angela, Greipp, Philip R., Litzow, Mark R., Henderson, Kimberly J., Van Wier, Scott A., Ahmann, Greg J., Fonseca, Rafael |
---|---|
Zdroj: | In Blood 15 October 2005 106(8):2837-2840 |
Databáze: | ScienceDirect |
Externí odkaz: |